Company profile
AJ1G, Inc.
OTC: AJYG · Healthcare · Medical - Pharmaceuticals
#1136 of 1,418 Healthcare companies by revenue
EA Score
——FH 85DQ —GM —SS 35
v0.1 · 35/100 weight · pillars only
↑ balance-sheet leverage, net margin · ↓ 3-yr revenue growth, market scale
Methodology →Revenue TTM
$39.2k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
$408
Employees
14
as of 2026-09-03
Market cap
$400.9k
as of 2026-09-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$8.6k$8.6k2025
Net income$408$4082025
Operating income$408$4082025
Total assets$105.5k$105.5k2025
Liabilities$300$3002025
Equity$105.2k$105.2k2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY20
FY21
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is AJ1G, Inc.’s revenue?
AJ1G, Inc. booked $8.6k in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a 4.7% net margin.
Peers · Healthcare
Baseline Productions, Inc.——SYBLEU Inc——Modern Mobility Aids, Inc.——Voyageur Pharmaceuticals Ltd.——Genelux Corporation32DBetter Therapeutics, Inc.——Neighbors
Broward →Key facts
CEOLiangtian Wen
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersCoconut Creek, FL
ExchangeOTC: AJYG
Employees14
IPO date2016-09-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.